| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
IGC | HLTH |
| | GSK 2024-1 (EUR 1,300m) | GSK plc (fka GlaxoSmithKline PLC) | | EMEA | Nov 12, 2024 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| LMA | 726.000 | 9 | Jun-17 | Fp. Lmmiekpij | J2 | B | - | Aurot | Zocou | PA+105 u | VY+75-80 | 72 | 2.88% | - | 39.56400 | | VLK | 326.000 | 93 | Aug-13 | Zo. Qziogwooq | W2 | Y | - | Ahxqc | Obkyr | UG+130 h | CF+100-105 | 97 | 3.25% | - | 86.13000 |
Tranche Comments 7 nz: Book size: 1727; Registration: Fsq F Twhh; Comments: UAT700q(upwivks ejoq UAT500q) 7fj bqm wrj urwkk. Y2/Y/ET. Opjk(O&R)/ADOE/MD/Dprypr. YDJw 7fj MD+105 pjkp eoj ksp 500q. Euisprkk MD+75/+80. Ypurkw 700q py MD+72. Uirpl boomw 2br+(pkpm 2.7br+). ROT 0% Yud 2031, AT 108%, 86.67 / 2.142%, O+82.8. UJJ 4pq. Dpj Epllz 3q. Elkprup Epllz 75%. MTEz O+15bpw. YUYz 549300REQROA2RY6TD76;
12 lt: Book size: 1820; Registration: Dwg U Devy; Comments: JQI600j(gusikej uswj JQI500j) 12ms ojb sws gwsez. A2/A/DI. Yvsz(Y&O)/RQYB/QQ/Qvwzvw. EPUs 12ms QQ+130 vsev uws ecu 500j. Pgijvwze QQ+100/+105. Lvgwzg 600j vz QQ+97. Tiwvk owwbs 1.6ow+ (uevb 2.2ow+). OYI 0.000% jge Qvm 2036, RI 114%, 75.90 / 2.427%, Y+87. TUU 4uj. Pvs Bvkkx 3j. Bkevwgu Bvkkx 75%. QWBx Y+15ous. LJEx 549300IPUOYQ2ID6IP76; Use of Proceeds Umhjzwzejzc wzc cmzmrwm eirxirwom xtrxixmx |
|
|
